Potently inhibits the desensitization of AMPA receptors. Antihypertensive.
Product Details
Alternative Name: | 3-Bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 6-Chloro-3,4-dihydro-3[2-norbornen-5-yl]-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide |
|
Formula: | C14H16ClN3O4S2 |
|
MW: | 389.9 |
|
CAS: | 2259-96-3 |
|
MI: | 14: 2754 |
|
Purity: | ≥98% (HPLC (UV)) |
|
Appearance: | White to off-white solid. |
|
Solubility: | Soluble in DMSO, methanol (36mg/ml) or dilute aqueous base (36mg/ml); insoluble in water. |
|
Shipping: | Ambient Temperature |
|
Long Term Storage: | +4°C |
|
Regulatory Status: | RUO - Research Use Only |
|
Please mouse over
Product Literature References
Enhanced long term potentiation and decreased AMPA receptor desensitization in the acute period following a single kainate induced early life seizure: H. O'Leary, et al. ; Neurobiol. Dis.
87, 134 (2015),
Application(s): Blocked AMPAR desensitization,
Abstract;
Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists: M.A. Desai, et al.; J. Pharmacol. Exp. Ther.
272, 38 (1995),
Abstract;
Inhibition by cyclothiazide of neuronal nicotinic responses in bovine chromaffin cells: J.M. Nooney & A. Feltz; Br. J. Pharmacol.
114, 648 (1995),
Abstract;
Modulation of AMPA/kainate receptors by cyclothiazide increases cytoplasmic free Ca2+ and 45Ca2+ uptake in brain neurons: G. Cebers & S. Liljequist; Eur. J. Pharmacol.
290, 105 (1995),
Abstract;
Cyclothiazide potentiates agonist responses at human AMPA/kainate receptors expressed in oocytes: R.L. Sharp, et al.; Eur. J. Pharmacol.
266, R1 (1994),
Abstract;
Desensitization of AMPA receptors upon multiquantal neurotransmitter release: L.O. Trussell, et al.; Neuron
10, 1185 (1993),
Abstract;
Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid- and kainate-preferring glutamate receptors: L.A. Wong & M.L. Mayer; Mol. Pharmacol.
44, 504 (1993),
Abstract;